Mini Review - Materials Science and Nanotechnology (2023) Volume 7, Issue 3
Recent progress in nanomaterials for biomedical applications.
Department of Biomolecular and Chemical Engineering, Chonnam National University, South Korea
- *Corresponding Author:
- Soon-Do Kim
Department of Biomolecular and Chemical Engineering
Chonnam National University
Received: 23-May-2023, Manuscript No. AAMSN-23-102705; Editor assigned: 25-May-2023, PreQC No. AAMSN-23-102705 (PQ); Reviewed: 01-Jun-2023, QC No. AAMSN-23-102705; Revised: 13-Jun-2023, Manuscript No. AAMSN-23-102705(R); Published: 17-Jun-2023, DOI:10.35841/aamsn-7.3.147
Citation: Kim S. Recent progress in nanomaterials for biomedical applications. Mater Sci Nanotechnol. 2023;7(3):147
Nanomaterials have emerged as promising tools in various biomedical applications due to their unique physical, chemical, and biological properties. This review highlights recent progress in the field of nanomaterials for biomedical applications, focusing on their potential in diagnosis, imaging, drug delivery, and tissue engineering.
Nanotechnology has revolutionized the field of biomedical research, providing novel solutions for diagnosing, treating, and monitoring diseases. Nanomaterials, defined as materials with at least one dimension less than 100 nanometers, offer unique properties that can be harnessed to address critical challenges in healthcare. In recent years, significant advancements have been made in the development of nanomaterials for various biomedical applications. This article highlights some of the recent progress and promising trends in this rapidly evolving field .
Nanoparticles have emerged as versatile carriers for targeted drug delivery, enhancing therapeutic efficacy while minimizing side effects. Recent breakthroughs have focused on improving nanoparticle stability, biocompatibility, and controlled release capabilities. Researchers have successfully employed various nanomaterials, including liposomes, dendrimers, and polymeric nanoparticles, for the targeted delivery of anticancer drugs, antibiotics, and gene therapy agents. Additionally, the incorporation of stimuli-responsive elements in nanoparticles allows for triggered drug release at specific disease sites, further enhancing treatment precision .
Nanosensors have shown great potential for early disease detection and monitoring. These tiny devices, capable of detecting specific biomarkers, offer high sensitivity and selectivity. Recent advances have seen the integration of nanomaterials such as carbon nanotubes, quantum dots, and metallic nanoparticles into sensing platforms. These nanosensors enable rapid and accurate detection of diseases, including cancer, infectious diseases, and neurodegenerative disorders. Moreover, advancements in wearable nanosensors have facilitated continuous monitoring of physiological parameters, leading to personalized healthcare and improved disease management. Tissue engineering aims to regenerate damaged or lost tissues using biomaterials, cells, and growth factors. Nanomaterials play a crucial role in this field by providing scaffolds with unique properties to support tissue growth and regeneration. Recent progress includes the development of nanofibrous scaffolds, hydrogels, and nanoparticles for applications in bone, cartilage, and vascular tissue engineering. These nanomaterial-based scaffolds mimic the native extracellular matrix, promoting cell adhesion, proliferation, and differentiation. Furthermore, bioactive nanoparticles can be incorporated into scaffolds to stimulate tissue regeneration and promote vascularization .
Nanotheranostics combines diagnostic imaging and therapeutic functions into a single nanoscale system. This emerging field has witnessed remarkable advancements in recent years, facilitating personalized medicine and improved patient outcomes. Multifunctional nanoparticles, such as iron oxide nanoparticles and quantum dots, enable simultaneous imaging and targeted therapy. These nanosystems offer real-time monitoring of treatment response, enabling physicians to make informed decisions. Nanotheranostics also hold great promise in image-guided surgeries, enhancing precision and minimizing invasiveness .
Nanotechnology has revolutionized biosensing and bioimaging techniques, allowing for improved sensitivity, resolution, and specificity. Nanomaterial-based biosensors enable rapid and ultrasensitive detection of biomolecules, pathogens, and toxins. Nanoprobes for bioimaging offer enhanced contrast, enabling the visualization of cellular and molecular processes. Recent progress in this area includes the development of plasmonic nanoparticles, fluorescent quantum dots, and upconversion nanoparticles. These nanomaterials have enabled breakthroughs in early disease detection, understanding cellular processes, and tracking drug delivery in real-time .
nanomaterials have made remarkable strides in biomedical applications, revolutionizing drug delivery, imaging, tissue engineering, and disease diagnosis. Their unique properties at the nanoscale level have enabled precise targeting, enhanced imaging capabilities, and improved therapeutic outcomes. With further research and development, nanomaterials hold immense potential to transform healthcare and improve patient outcomes in the near future. However, it is crucial to address the safety and scalability challenges associated with nanomaterials to ensure their widespread adoption and clinical translation.
- Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem Soc Rev. 2012;41(6):2256-82.
- Riley PR, Narayan RJ. Recent advances in carbon nanomaterials for biomedical applications: A review. Curr Opin Biomed Eng. 2021;17:100262.
- Duan C, Liang L, Li L, et al. Recent progress in upconversion luminescence nanomaterials for biomedical applications. J Mater Chem B. 2018;6(2):192-209.
- Liu WL, Zou MZ, Qin SY, et al . Recent advances of cell membrane?coated nanomaterials for biomedical applications. Adv Funct Mater. 2020;30(39):2003559.
- Erol O, Uyan I, Hatip M, et al. Recent advances in bioactive 1D and 2D carbon nanomaterials for biomedical applications. Nanomedicine. 2018;14(7):2433-54.